Lungenfachklinik Immenhausen — Clinical Trial Site

11 Registered trials

6 Currently recruiting

Organisation

Lungenfachklinik Immenhausen

Location

Immenhausen, Germany

Identifier

ORL-000000662

Address

Robert-Koch-Str. 3, 34376, Germany

Departments

Fachklinik für Lungenerkrankungen
Lungenfachklinik Immenhausen
N/A
NA
Thoraxonkologie
Zentrum fuer Pneumologie, Allergologie, Schlaf- und Beatmungsmedizin

Clinical trials at this site (11)

Search interface

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis Recruiting

2023-503699-25-00 Progressive Pulmonary Fibrosis 5 2024-07-15
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis Recruiting

2023-503697-21-01 Idiopathic pulmonary fibrosis 5 2024-06-24
A Study of Repotrectinib versus Crizotinib in Participants with Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-po… Recruiting

2023-505604-32-00 Non small cell lung cancer (NSCLC) 5 2024-01-24
A Study to Learn About the Study Medicine Called PF-08046054/SGNPDL1V Versus Docetaxel in Adult Participants with Previously-treated Program… Recruiting

2025-521281-97-00 Non-Small Cell Lung Cancer (NSCLC) 5 2025-12-02
A Study in TKI-naive Patients With Advanced ALK-Positive NSCLC ( ALKAZAR ) Recruiting

2024-517553-26-00 Advanced ALK-positive non-small cell lung cancer (NSCLC 5 2025-11-12
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
A study for GSK3862995B in healthy participants and participants with Chronic Obstructive Pulmonary Disease Ended

2023-506880-32-01 Pulmonary Disease, Chronic Obstructive 1 2025-04-14
Phase 2 study to evaluate the efficacy and safety of GSK3915393 in participants with Idiopathic Pulmonary Fibrosis (IPF) Ended

2023-509371-16-00 Idiopathic Pulmonary Fibrosis 4 2024-09-25
A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended

2023-508395-11-00 idiopathic pulmonary fibrosis 4 2024-09-10
A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease Ended

2022-502234-70-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-07-14
TSRO-Ph2, Dostarlimab +CT vs Pembro +CT, 1L H2H efficacy comparison in Metastatic NSCLC pts. PERLA Ended

2023-505894-33-00 Lung Cancer, Non-Small Cell 4 2020-11-25